Phase I-II trial of hypofractionated conformal proton beam radiation therapy for favorable-risk prostate cancer,
Role: Investigator,
LLU Dept. of Radiation Medicine,
(12/2025 - 12/2026)
Status: Approved
Radiation medicine research registry,
Role: Investigator,
LLU Dept. of Radiation Medicine,
(09/2025 - 09/2026)
Status: Approved
Non-Profit Organization
A prospective comparative study of outcomes with proton and photon radiation in prostate cancer (COMPPARE),
Role: Investigator,
Patient-Centered Outcomes Research Institute (PCORI),
(07/2025 - 07/2026)
Status: Approved